The puzzling inflammatory bowel disease: growing interest for mediators of inflammation.
作者信息
Zijlstra F J
机构信息
Department of Pharmacology Faculty of Medicine and Health Sciences Erasmus University P.O. Box 1738 Rotterdam 3000 DR The Netherlands.
出版信息
Mediators Inflamm. 1997;6(2):83-4. doi: 10.1080/09629359791767.
Abstract
摘要
相似文献
1
The puzzling inflammatory bowel disease: growing interest for mediators of inflammation.令人困惑的炎症性肠病：对炎症介质的兴趣与日俱增。
Mediators Inflamm. 1997;6(2):83-4. doi: 10.1080/09629359791767.
2
Resolution of inflammation in inflammatory bowel disease.炎症性肠病的炎症消退。
Lancet Gastroenterol Hepatol. 2017 Jul;2(7):521-530. doi: 10.1016/S2468-1253(17)30031-6. Epub 2017 Apr 12.
3
Maresins: anti-inflammatory pro-resolving mediators with therapeutic potential.马雷斯汀：具有治疗潜力的抗炎性促解决介质。
Eur Rev Med Pharmacol Sci. 2020 Jul;24(13):7442-7453. doi: 10.26355/eurrev_202007_21913.
4
MicroRNAs and Inflammation in Colorectal Cancer.微小RNA与结直肠癌中的炎症
Adv Exp Med Biol. 2016;937:53-69. doi: 10.1007/978-3-319-42059-2_3.
5
EPA- and DHA-derived resolvins' actions in inflammatory bowel disease.源自二十碳五烯酸（EPA）和二十二碳六烯酸（DHA）的消退素在炎症性肠病中的作用。
Eur J Pharmacol. 2016 Aug 15;785:156-164. doi: 10.1016/j.ejphar.2015.08.050. Epub 2015 Aug 29.
6
Mediators of inflammation: production and implication in inflammatory bowel disease.
Hepatogastroenterology. 1998 Sep-Oct;45(23):1601-9.
7
Actors and Factors in the Resolution of Intestinal Inflammation: Lipid Mediators As a New Approach to Therapy in Inflammatory Bowel Diseases.肠道炎症消退中的作用者与因素：脂质介质作为炎症性肠病治疗的新方法
Front Immunol. 2017 Oct 23;8:1331. doi: 10.3389/fimmu.2017.01331. eCollection 2017.
8
Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators.单核细胞/巨噬细胞在炎症性肠病中作用的当前概念——促炎介质与免疫抑制介质的平衡
Ital J Gastroenterol Hepatol. 1998 Jun;30(3):338-44.
9
The multifaceted mast cell in inflammatory bowel disease.炎症性肠病中的多面肥大细胞。
Inflamm Bowel Dis. 2014 Dec;20(12):2364-78. doi: 10.1097/MIB.0000000000000142.
10
[What the surgeon needs to know about basic new concepts of inflammation and their therapeutic consequences: sanitation of inflammation is not a passive but rather an active process regulated by lipid mediators].外科医生需要了解的炎症基本新概念及其治疗后果：炎症的清除并非被动过程，而是由脂质介质调节的主动过程
Zentralbl Chir. 2013 Jun;138(3):322-30. doi: 10.1055/s-0032-1328182. Epub 2013 Jun 27.
本文引用的文献
1
The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release.白介素受体拮抗剂（IL-1ra）对结肠细胞花生四烯酸释放的影响。
Mediators Inflamm. 1996;5(6):449-52. doi: 10.1155/S0962935196000622.
2
Nitric oxide as a mediator of gastrointestinal mucosal injury?-Say it ain't so.一氧化氮作为胃肠道黏膜损伤的介质？- 这不可能。
Mediators Inflamm. 1995;4(6):397-405. doi: 10.1155/S0962935195000640.
3
Nitric oxide as a mediator of inflammation?-You had better believe it.一氧化氮作为炎症的介质？-你最好相信它。
Mediators Inflamm. 1995;4(6):387-96. doi: 10.1155/S0962935195000639.
4
Human colonic intraepithelial lymphocytes regulate the cytokines produced by lamina propria mononuclear cells.人类结肠上皮内淋巴细胞调节固有层单核细胞产生的细胞因子。
Mediators Inflamm. 1997;6(2):105-9. doi: 10.1080/09629359791794.
5
Cytokines in inflammatory bowel disease.炎症性肠病中的细胞因子。
Mediators Inflamm. 1997;6(2):95-103. doi: 10.1080/09629359791785.
6
Leukocyte migration in experimental inflammatory bowel disease.实验性炎症性肠病中的白细胞迁移。
Mediators Inflamm. 1997;6(2):85-93. doi: 10.1080/09629359791776.
7
In-vivo effect of nicotine on cytokine production by human non-adherent mononuclear cells.
Eur J Gastroenterol Hepatol. 1996 Oct;8(10):1017-20. doi: 10.1097/00042737-199610000-00016.
8
Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.半抗原诱导的小鼠炎症性肠病模型：黏膜免疫反应及耐受性保护
J Immunol. 1996 Sep 1;157(5):2174-85.
9
Immunosuppressive and anti-inflammatory properties of interleukin 10.白细胞介素10的免疫抑制和抗炎特性。
Ann Med. 1995 Oct;27(5):537-41. doi: 10.3109/07853899509002465.
10
Effect of nicotine on rectal mucus and mucosal eicosanoids.尼古丁对直肠黏液和黏膜类二十烷酸的影响。
Gut. 1994 Feb;35(2):247-51. doi: 10.1136/gut.35.2.247.
Zotero 插件